The Global Breast Imaging Market Growth Accelerated By Increasing Need For Early Detection Of Breast Cancer
Breast imaging products are medical imaging methods used for the early detection, diagnosis, and screening of breast diseases including breast cancer. Mammography, breast MRI, and breast ultrasound are some commonly used breast imaging techniques. Mammography provides high-resolution images of breast tissues and is considered as the gold standard for breast cancer screening. However, breast MRI and ultrasound offer additional information and have better performance in women with dense breasts.
The global Breast Imaging Market is estimated to
be valued at US$ 4840.71 Mn in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2024 to 2031, as
highlighted in a new report published by Coherent Market Insights.
Market key trends: The increasing need for early detection of breast cancer has
been a major factor driving the growth of breast imaging market over the past
few years. Breast cancer screening through mammography and other techniques
enables early detection when the disease is most treatable. According to the
WHO, around 1 in 8 women worldwide are diagnosed with breast cancer during
their lifetime. Moreover, breast cancer is the leading cause of cancer death
among women. Regular breast screening helps reduce breast cancer mortality by
finding cancers early when they are most treatable. This has significantly
increased the adoption of breast imaging technologies globally in recent years.
Various awareness campaigns by governments and cancer organizations have also
emphasized on the importance of routine breast screening through breast
imaging.
Segment Analysis
Mammography dominates the breast imaging market currently due to its
effectiveness in early detection of breast cancer owing to improved imaging
technology. It holds around 60% of the total market share. Digital mammography
is gaining higher adoption compared to analog mammography as it uses lower
radiation dose and produces clearer images.
Key Takeaways
The global Breast
Imaging Market Demand is
expected to witness high growth. The global Breast Imaging Market is estimated
to be valued at US$ 4840.71 Mn in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2024 to 2031.
Regional analysis shows that
North America region currently dominates the market due to early adoption of
advanced breast imaging technologies and higher healthcare spending. Asia
Pacific is expected to be the fastest growing region due to increasing
awareness about breast cancer, large patient population and rising healthcare
expenditure. Several initiatives taken by governments and non-profit
organizations to spread awareness and improved access to screening and
diagnostic services are aiding early detection in the region.
Key players operating in the Breast Imaging market are Stemson Therapeutics,
OliX Pharmaceuticals, Inc, Pfizer Inc, Aclaris Therapeutics, Inc., Fagron,
Follicum AB, Cipla Inc., Arcutis Biotherapeutics, Dr. Reddy€TMs Laboratories
Ltd., Himalaya Wellness Company, Stemson Therapeutics, Cosmo Pharmaceuticals
N.V., Equillium, Inc., Eli Lilly and Company, Concert Pharmaceuticals Inc., and
Teva Pharmaceutical Industries Ltd.
Key players operating in the Breast Imaging market are focusing on new product
launches, collaborations and geographic expansions to strengthen their market
position. For instance, Stemson Therapeutics launched various clinical trials
to evaluate its stem cell therapy candidates for breast cancer. OliX
Pharmaceuticals, Inc signed partnerships to develop novel oligonucleotide
therapies for breast cancer.
Explore more related article on this topic: https://www.newsanalyticspro.com/the-global-breast-imaging-market-growth/
https://techaxen.com/medicine-testing-services-in-the-us-ensuring-product-safety-and-compliance/

Comments
Post a Comment